After Years of Customer Demand, Epocrates Releases iPad app

Epocrates, an industry-leading clinical decision support platform popular with physicians, releases an iPad optimized version of their app today.

The Epocrates user base has eroded modestly over the past two years, primarily due to its lack of an iPad app as that device’s popularity among physicians has grown.

The expectation of an iPad app started almost exactly two years ago, when Epocrates acquired Modality Inc., a medical app developer, for $13.8 million. Epocrates already had a widely popular iPhone app at that time, so expectations of an iPad app for the recently launched device were reasonable.

Since that time, the company has launched and sold a failed EMR system and navigated an IPO, going public in February 2011. Stock trends since the IPO have mirrored overall user erosion closely. EPOC stock closed after its first day of trading at $27.55 but has tumbled 62 percent since, closing Thursday at $9.57.

↑ Back to top

Founding Sponsors

Platinum Sponsors